Total Payments
$6,448
2024 Payments
$361.68
Companies
49
Transactions
310
Medicare Patients
11,056
Medicare Billing
$588,202
Payment Breakdown by Category
Food & Beverage$5,997 (93.0%)
Education$451.35 (7.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,997 | 295 | 93.0% |
| Education | $451.35 | 6 | 7.0% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$6,448
301 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,426 | 70 | $0 (2023) |
| Coloplast Corp | $638.21 | 32 | $0 (2023) |
| PFIZER INC. | $387.73 | 22 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $288.03 | 3 | $0 (2023) |
| Verity Pharmaceuticals Inc. | $275.42 | 13 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $247.78 | 16 | $0 (2024) |
| Teleflex LLC | $208.96 | 8 | $0 (2023) |
| Boston Scientific Corporation | $189.01 | 10 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $179.25 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $167.44 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.68 | 18 | Verity Pharmaceuticals Inc. ($93.98) |
| 2023 | $1,115 | 39 | PROCEPT BioRobotics Corporation ($265.46) |
| 2022 | $1,269 | 52 | Astellas Pharma US Inc ($308.35) |
| 2021 | $1,271 | 63 | Astellas Pharma US Inc ($336.65) |
| 2020 | $666.47 | 40 | Coloplast Corp ($134.01) |
| 2019 | $680.17 | 41 | Astellas Pharma US Inc ($302.02) |
| 2018 | $605.26 | 30 | Astellas Pharma US Inc ($208.26) |
| 2017 | $480.49 | 27 | Astellas Pharma US Inc ($143.28) |
All Payment Transactions
310 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: Prostate cancer | ||||||
| 10/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: Prostate cancer | ||||||
| 08/06/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: UROLOGY | ||||||
| 05/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: UROLOGY | ||||||
| 04/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diagnostic Imaging | ||||||
| 01/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Prostate cancer | ||||||
| 01/25/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Prostate cancer | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/21/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Prostate cancer | ||||||
| 12/21/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Prostate cancer | ||||||
| 12/15/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/07/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/01/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/24/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Oncology | ||||||
| 10/23/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,624 | 24,197 | $496,757 | $142,945 |
| 2022 | 34 | 2,738 | 29,384 | $585,990 | $147,246 |
| 2021 | 38 | 2,735 | 25,599 | $654,855 | $158,475 |
| 2020 | 37 | 2,959 | 29,108 | $563,960 | $139,536 |
Total Patients
11,056
Total Services
108,288
Medicare Billing
$588,202
Procedure Codes
142
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 125 | 919 | $59,735 | $39,356 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 312 | $93,600 | $27,522 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 216 | $43,200 | $13,455 | 31.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 72 | $54,000 | $9,662 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 153 | 169 | $20,280 | $6,622 | 32.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 35 | 38 | $20,900 | $6,192 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $18,600 | $4,306 | 23.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 95 | $7,600 | $3,287 | 43.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 153 | 176 | $14,080 | $3,172 | 22.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 384 | 458 | $32,130 | $3,168 | 9.9% |
| 51705 | Simple change of bladder tube | Office | 2023 | 29 | 39 | $9,750 | $2,673 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $9,480 | $2,376 | 25.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 28 | 40 | $9,200 | $2,209 | 24.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 21 | $29,150 | $2,201 | 7.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 36 | 46 | $8,740 | $1,955 | 22.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 24 | 27 | $9,605 | $1,698 | 17.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 171 | 199 | $1,990 | $1,664 | 83.6% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 46 | 48 | $7,200 | $1,512 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,700 | $1,487 | 26.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 35 | $3,850 | $1,330 | 34.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 471 | 607 | $7,284 | $1,325 | 18.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 65 | 118 | $8,260 | $1,151 | 13.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 28 | 34 | $3,570 | $859.86 | 24.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 12 | 12 | $3,720 | $779.43 | 21.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 43 | 57 | $1,995 | $762.16 | 38.2% |
About Dr. Stephen Confer, M.D
Dr. Stephen Confer, M.D is a Urology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841345709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Confer, M.D has received a total of $6,448 in payments from pharmaceutical and medical device companies, with $361.68 received in 2024. These payments were reported across 310 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,997).
As a Medicare-enrolled provider, Confer has provided services to 11,056 Medicare beneficiaries, totaling 108,288 services with total Medicare billing of $588,202. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Tulsa, OK
- Active Since 01/23/2007
- Last Updated 07/05/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841345709
Products in Payments
- XTANDI (Drug) $555.84
- MYRBETRIQ (Drug) $534.01
- SpeediCath (Device) $326.44
- Trelstar (Drug) $275.42
- AQUABEAM ROBOTIC SYSTEM (Device) $265.46
- XIAFLEX (Biological) $247.78
- Myrbetriq (Drug) $216.58
- PROVENGE (Drug) $179.25
- UROLIFT (Device) $162.89
- JELMYTO (Drug) $138.45
- CONTINENCE CARE (Device) $134.01
- KEYTRUDA (Biological) $132.62
- ELIGARD (Drug) $126.17
- GIAPREZA (Drug) $124.83
- Peristeen (Device) $123.54
- Smith & Nephew Insufflator 500 (Device) $118.61
- GEMTESA (Drug) $118.45
- Prolia (Biological) $117.39
- Axumin (Drug) $112.05
- ORGOVYX (Drug) $111.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tulsa
Dr. Melanie Ketchandji, M.d, M.D
Urology — Payments: $90,749
Urology $90,749
Scott Litwiller, Md, MD
Urology — Payments: $41,382
Urology $41,382
Dr. Sean Doyle, M.d, M.D
Urology — Payments: $31,400
Urology $31,400
Charles Pritchard, Md, MD
Urology — Payments: $24,283
Urology $24,283
Marc Milsten, Md, MD
Urology — Payments: $23,702
Urology $23,702
Dr. Curtis Powell, M.d, M.D
Urology — Payments: $17,755
Urology $17,755